Acetaldehyde adducts with serum proteins: effect on diazepam and phenytoin binding.
The in vitro effects of acetaldehyde treatment on the binding of phenytoin and diazepam to human serum albumin (HSA) and human serum proteins (HSP) have been investigated. The incorporation of acetaldehyde into proteins following incubation with different concentrations of [1,2-14 C]-acetaldehyde (0.5, 25, 100 mmol/l) was carried out. The proteins were then dialyzed so that only the stable adduct was retained. Binding of phenytoin and diazepam was then studied. Scatchard plot analysis showed a slight decrease (p less than 0.01 for HSP and 25 mmol/l acetaldehyde) in the number of binding sites for phenytoin when the acetaldehyde/protein ratio was increased. The affinity constant was also increased (p less than 0.01) with 100 mmol/l acetaldehyde. No change could be demonstrated in the number of diazepam binding sites on HSA; an increase in the binding capacity of HSP was shown following incubation with 25 mmol/l acetaldehyde. The fraction of drug bound at therapeutic levels has been also calculated for both drugs. An increase for diazepam but no change for phenytoin can be observed before or after treatment of proteins with acetaldehyde.
D000079:Acetaldehyde / Q000378:metabolism*; D000437:Alcoholism / Q000378:metabolism; D001665:Binding Sites; D001798:Blood Proteins / Q000378:metabolism*; D003975:Diazepam / Q000378:metabolism*; D000431:Ethanol / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D010672:Phenytoin / Q000378:metabolism*; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism
D001798:Blood Proteins; D012709:Serum Albumin; D000431:Ethanol; D010672:Phenytoin; D000079:Acetaldehyde; D003975:Diazepam